Bionano Genomics to Report First Quarter 2021 Financial Results and Host a Conference Call and Webcast on May 13, 2021
May 06 2021 - 4:01PM
Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will
host a conference call and live webcast on Thursday, May 13, 2021
at 4:30 p.m. Eastern Time to report financial results for the first
quarter ended March 31, 2021 and to highlight recent corporate
progress.
Conference call & Webcast Details
Date: |
Thursday, May 13, 2021 |
Time: |
4:30 p.m. Eastern Time |
Toll Free: |
(833) 397-0959 |
International: |
(614) 999-1719 |
Conference ID: |
7163806 |
Webcast: |
https://edge.media-server.com/mmc/p/5hjudqv7 |
To access the call, participants should dial the applicable
telephone number above at least 5 minutes prior to the start of the
call. An archived version of the webcast will be available for
replay in the Investors section of the Bionano website.
About Bionano GenomicsBionano is a genome
analysis company providing tools and services based on its Saphyr
system to scientists and clinicians conducting genetic research and
patient testing, and providing diagnostic testing for those with
autism spectrum disorder (ASD) and other neurodevelopmental
disabilities through its Lineagen business. Bionano’s Saphyr system
is a research use only platform for ultra-sensitive and
ultra-specific structural variation detection that enables
researchers and clinicians to accelerate the search for new
diagnostics and therapeutic targets and to streamline the study of
changes in chromosomes, which is known as cytogenetics. The Saphyr
system is comprised of an instrument, chip consumables, reagents
and a suite of data analysis tools. Bionano provides genome
analysis services to provide access to data generated by the Saphyr
system for researchers who prefer not to adopt the Saphyr system in
their labs. Lineagen has been providing genetic testing services to
families and their healthcare providers for over nine years and has
performed over 65,000 tests for those with neurodevelopmental
concerns. For more information,
visit www.bionanogenomics.com or www.lineagen.com.
CONTACTSCompany Contact:Erik
Holmlin, CEOBionano Genomics, Inc.+1 (858)
888-7610eholmlin@bionanogenomics.com
Investor Relations and Media
Contact:Amy ConradJuniper Point+1 (858)
366-3243amy@juniper-point.com
Bionano Genomics (NASDAQ:BNGO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bionano Genomics (NASDAQ:BNGO)
Historical Stock Chart
From Sep 2023 to Sep 2024